Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7255 results

Sort By:

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

Study ID: NCT03810196
Start Date: 2019-03-01
End Date: 2027-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback

Sponsor

Children's Hospital of Philadelphia

Source: clinicaltrials.gov

Share:
Add to list

3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial

Study ID: NCT05674396
Start Date: 2023-06-30
End Date: 2027-09-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

108

Intervention / Treatment

Stereotactic body radiotherapy

Traditional Palliation

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Study ID: NCT03819296
Start Date: 2021-02-21
End Date: 2025-10-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

800

Intervention / Treatment

Best Practice

Biospecimen Collection

Endoscopic Procedure

Fecal Microbiota Transplantation

Infliximab

Laboratory Biomarker Analysis

Prednisone

Vedolizumab

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure

Study ID: NCT02464696
Start Date: 2015-10-06
End Date: 2026-10-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

256

Intervention / Treatment

Methylprednisolone

Oxygen Therapy

Positive Air Pressure Device

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring

Study ID: NCT05054296
Start Date: 2020-03-23
End Date: 2027-02-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

200

Intervention / Treatment

Educational Intervention

Exercise Intervention

FitBit

Quality-of-Life Assessment

Administration questionnaire

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma

Study ID: NCT04251416
Start Date: 2020-03-17
End Date: 2026-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

Sacituzumab Govitan

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list

Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control

Study ID: NCT03351348
Start Date: 2017-11-16
End Date: 2026-11
Study Type

Interventional

Study Phase

Phase3

No. of Participants

144

Intervention / Treatment

Bupivacaine

patient-reported pain scores

saline

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer

Study ID: NCT06483048
Start Date: 2024-09-20
End Date: 2028-09-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

12

Intervention / Treatment

Autologous MUC1-activated T-cells

Bendemustine

Biospecimen Collection

Computed Tomography

Cyclophosphamide

Echocardiography

Leukapheresis

Magnetic Resonance Imaging

Multigated Acquisition Scan

Positron Emission Tomography

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients

Study ID: NCT05274048
Start Date: 2022-06-24
End Date: 2027-06
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

Neratinib pill

FAM-DRASTUZUMAB DERUXTECAN-NXKI (TDXD)

Sponsor

Fox Chase Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Female Asian Nonsmoker Screening Study

Study ID: NCT05164757
Start Date: 2021-03-01
End Date: 2033-03
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment
Sponsor

NYU Langone Health

Source: clinicaltrials.gov

Share:
Add to list